Actively Recruiting
Artificial Liver Support Using DPMAS and Therapeutic Plasma Exchange for Adults With Acute or Acute on Chronic Liver Failure to Improve Organ Function and Coagulation
Led by Institute for Clinical and Experimental Medicine · Updated on 2026-01-09
25
Participants Needed
1
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the artificial liver support system ALSS for patients with acute on chronic liver failure ACLF or acute liver failure ALF. The study aims to assess the effects of a combined molecular adsorption system with double plasma DPMAS and therapeutic plasma exchange TPE on primary blood clotting, inflammation, and the function of vital organs. This approach seeks to improve clinical conditions and support liver regeneration or prepare patients for liver transplantation. Participants are divided into two groups one receives ALSS therapy alongside standard care, and the other receives standard care alone without ALSS. ALSS sessions involve alternating treatments with DPMAS and TPE, conducted for up to 7 to 10 days or until liver transplantation or recovery of liver function. The study does not involve randomization or masking. During the study, participants will be monitored for survival without liver transplant at 21 days after the first ALSS session, along with overall survival rates at 21 and 90 days. Researchers will also track the liver transplantation rate and timing within 90 days. The study involves hospitalized patients in intensive care units and includes assessments of organ function and coagulation. Participants may be followed up through day 28 and beyond for outcome evaluations.
CONDITIONS
Brief Title
ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF
Research Team
P
Petr Piza, MD, MHA
E
Eva Kieslichova, ass. prof., MD, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here